Majid Marjani

InstitutionShahid beheshti university of medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 25 Covid-19 publications, with a maximum of 5 publications in November 2020
    All Publications
    Bar chart showing 82 publications over 13 distinct years, with a maximum of 16 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vasheghani M, Jannati N, Baghaei P, Rezaei M, Aliyari R, Marjani M. The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality. Sci Rep. 2021 09 02; 11(1):17594. PMID: 34475485.
      Citations: 2     Fields:    Translation:Humans
    2. Rezaei M, Baghaei P, Sadr M, Moniri A, Babamahmoodi A, Qadimi S, Porabdollah M, Nadji SA, Tabarsi P, Marjani M. Diagnosis of COVID-19 by Serology in Admitted Patients with Negative RT-PCR Assay. Iran J Allergy Asthma Immunol. 2021 Aug 07; 20(4):394-401. PMID: 34418893.
      Citations:    Fields:    Translation:Humans
    3. Rezaei M, Mahmoudi S, Mortaz E, Marjani M. Immune cell profiling and antibody responses in patients with COVID-19. BMC Infect Dis. 2021 Jul 05; 21(1):646. PMID: 34225645.
      Citations:    Fields:    Translation:HumansCells
    4. Mortaz E, Tabarsi P, Jamaati H, Dalil Roofchayee N, Dezfuli NK, Hashemian SM, Moniri A, Marjani M, Malekmohammad M, Mansouri D, Varahram M, Folkerts G, Adcock IM. Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727. PMID: 33968010.
      Citations: 2     Fields:    Translation:Humans
    5. Tolouian R, Mulla ZD, Jamaati H, Babamahmoodi A, Marjani M, Eskandari R, Dastan F. Effect of bromhexine in hospitalized patients with COVID-19. J Investig Med. 2021 Mar 15. PMID: 33722999.
      Citations: 1     Fields:    
    6. Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947. PMID: 33607104.
      Citations: 12     Fields:    Translation:Humans
    7. Rezaei M, Marjani M, Mahmoudi S, Mortaz E, Mansouri D. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19. Int Arch Allergy Immunol. 2021; 182(3):254-262. PMID: 33498051.
      Citations: 7     Fields:    Translation:HumansCells
    8. Mortaz E, Bassir A, Dalil Roofchayee N, Dezfuli NK, Jamaati H, Tabarsi P, Moniri A, Rezaei M, Mehrian P, Varahram M, Marjani M, Mumby S, Adcock IM. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407. PMID: 33631512.
      Citations: 1     Fields:    Translation:Humans
    9. Rezaei M, Sadeghi M, Korourian A, Tabarsi P, Porabdollah M, Askari E, Mortaz E, Mahmoudi S, Marjani M, Velayati AA. Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens. Hum Antibodies. 2021; 29(2):109-113. PMID: 33720878.
      Citations:    Fields:    Translation:HumansCells
    10. Baghaei P, Dastan F, Marjani M, Moniri A, Abtahian Z, Ghadimi S, Valizadeh M, Heshmatnia J, Sadat Mirenayat M, Abedini A, Kiani A, Eslaminejad A, MohammadReza Hashemian S, Jamaati H, Zali A, Akbar Velayati A, Tabarsi P. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329. PMID: 33412395.
      Citations: 9     Fields:    Translation:Humans
    11. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec; 27(6):486-492. PMID: 33358260.
      Citations: 7     Fields:    Translation:HumansCells
    12. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Mortaz E, Tabarsi P, Marjani M, Malekmohammad M, Dastan F, Mortazavi SM, Sadr M, Idani E, Khoundabi B, Mohamadnia A, Abedini A, Kiani A, Moniri A, Nadji SA, Yassari F, Mokhber Dezfuli M, Pourabdollah M, Varahram M, Eshaghi F, Malekpour M, Velayati A. Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299. PMID: 33959166.
      Citations: 1     
    13. Babamahmoodi A, Moniri A, Sadr M, Poorhosseini SM, Rezaei M, Marjani M, Velayati AA. Trisomy 21 as a Risk Factor for Severe Illness in COVID-19: Report of two Cases. Tanaffos. 2020 Dec; 19(4):413-417. PMID: 33959180.
      Citations:    
    14. Tabarsi P, Barati S, Jamaati H, Haseli S, Marjani M, Moniri A, Abtahian Z, Dastan A, Yousefian S, Eskandari R, Saffaei A, Monjazebi F, Vahedi A, Dastan F. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205. PMID: 33214093.
      Citations: 18     Fields:    Translation:Humans
    15. Rezaei M, Babamahmoodi A, Marjani M. Bruton's Tyrosine Kinase: A Promising Target for the Treatment of COVID-19. Tanaffos. 2020 Nov; 19(2):85-88. PMID: 33262793.
      Citations: 3     
    16. Citations: 2     
    17. Mohammadpour H, Ziai A, Sadr M, Rezaei M, Marjani M, Tabarsi P. A Novel Coronavirus Disease (COVID-19): a Review of Host Cell Signaling Pathways. Tanaffos. 2020 Nov; 19(2):108-111. PMID: 33262797.
      Citations: 3     
    18. Baghaei P, Nadji SA, Marjani M, Moniri A, Hashemian SM, Sheikhzade H, Abtahian Z, Heshmatnia J, Abedini A, Jamaati H, Mansourafshar B, Ahmadi ZH, Mokhber Dezfuli M, Seifi S, Sadeghi M, Mirenayat MS, Yassari F, Lookzadeh S, Farzanegan B, Kiani A, Vasheghani M, Dastan F, Eslaminejad A, Malekmohammad M, Varahram M, Zali A, Tabarsi P, Velayati AA. Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128. PMID: 33262799.
      Citations:    
    19. Sadegh Beigee F, Pourabdollah Toutkaboni M, Khalili N, Nadji SA, Dorudinia A, Rezaei M, Askari E, Farzanegan B, Marjani M, Rafiezadeh A. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients. Pathol Res Pract. 2020 Oct; 216(10):153228. PMID: 32979740.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    20. Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869. PMID: 32889241.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    21. Mahmoudi S, Rezaei M, Mansouri N, Marjani M, Mansouri D. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm. J Clin Immunol. 2020 10; 40(7):974-976. PMID: 32648027.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    22. Mansouri N, Marjani M, Tabarsi P, von Garnier C, Mansouri D. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Immunol Invest. 2021 Nov; 50(8):884-890. PMID: 32633162.
      Citations: 6     Fields:    Translation:Humans
    23. Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688. PMID: 32544867.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    24. Dastan F, Tabarsi P, Marjani M, Moniri A, Hashemian SMR, Tavakoli-Ardakani M, Saffaei A. Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces. Iran J Pharm Res. 2020; 19(1):1-2. PMID: 32922463.
      Citations: 6     
    25. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36. PMID: 32922466.
      Citations: 15     
    26. Moniri A, Marjani M, Tabarsi P, Yadegarynia D, Nadji SA. Health Care Associated Middle East Respiratory Syndrome (MERS): A Case from Iran. Tanaffos. 2015; 14(4):262-7. PMID: 27114729.
      Citations: 4     
    Marjani's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (121)
    Explore
    _
    Co-Authors (95)
    Explore
    _
    Similar People (60)
    Explore
    _